Skip to Content

Overview

  • Deadline:
  • Upcoming
Company Name: Company Name: MaxLinear, Inc.
Stock Symbol: Stock Symbol: MXL
MaxLinear, Inc. (NASDAQ: MXL): MaxLinear is being investigated for violations of the federal securities laws in connection with potential false and misleading statements made to investors and a subsequent significant price decline in the stock.
 
If you incurred losses on your investments in MaxLinear, you are encouraged to submit your information.
 
Why is MaxLinear being Investigated?

MaxLinear provides integrated radio-frequency analog and mixed-signal semiconductor products for broadband communications applications. The company discussed how it had strong visibility into its channel inventories, and how it did not have a large overhang of product in its channel.
 
After the market closed on July 24, 2024, MaxLinear announced earnings results for its second quarter of 2024 and that net revenue for the quarter was just $92 million, down 50% year-over-year. The company attributed the decline at least in part to prolonged burn-off of excess customer inventory leading to weakened demand. Multiple Wall Street analysts cut their price targets on MaxLinear, and at least one analyst questioned the company’s claimed visibility into its channel inventories.
 
The Stock Declines as the Truth is Revealed
 
The news caused a precipitous decline in the price of MaxLinear stock. The price of the company’s stock closed at $22.29 per share on July 24, 2024. Prior to the market open on July 25, 2024, MaxLinear stock was trading in the range of $16.40 per share, a decline of $5.89 per share, or 26%.

What are my Rights?

If you incurred losses on your investments in MaxLinear, you are encouraged to submit your information to speak with an attorney about your rights.

You can also contact:
Ross Shikowitz
ross@bfalaw.com
212-789-3619

All representation is on a contingency fee basis. Shareholders are not responsible for any court costs or expenses of litigation. The Firm will seek court approval for any potential fees and expenses.

Why Bleichmar Fonti & Auld LLP?

BFA is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It was named among the Top 5 plaintiff law firms by ISS SCAS in 2023 and its attorneys have been named Titans of the Plaintiffs’ Bar by Law360 and SuperLawyers by Thompson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.’s Board of Directors (pending court approval), as well as $420 million from Teva Pharmaceutical Ind. Ltd.
 
Attorney advertising. Past results do not guarantee future outcomes.
 
Contact Us For
More Information

You may share a link to this page on any of the sites listed below or send link via email:

This website uses cookies to improve user experience. By using our website you consent to all cookies in accordance with our Cookie Policy.

Accept & Hide Message